GNLK.Q logo

GeneLink Stock Price

Symbol: OTCPK:GNLK.QMarket Cap: US$10.6kCategory: Pharmaceuticals & Biotech

GNLK.Q Share Price Performance

GNLK.Q Community Fair Values

    Recent GNLK.Q News & Updates

    No updates

    GeneLink, Inc. Key Details

    US$1.6m

    Revenue

    US$1.3m

    Cost of Revenue

    US$306.4k

    Gross Profit

    US$2.5m

    Other Expenses

    -US$2.2m

    Earnings

    Last Reported Earnings
    Sep 30, 2013
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    0
    Gross Margin
    0%
    Net Profit Margin
    0%
    Debt/Equity Ratio
    0%

    GeneLink, Inc. Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About GNLK.Q

    Founded
    1994
    Employees
    n/a
    CEO
    Bernard Kasten
    WebsiteView website
    www.genelinkbio.com

    GeneLink, Inc. offers 12-gene DNA assessment services. The company also provides health custom supplements. In addition, it formulates a line of skin care products. The company was founded in 1994 and is based in Orlando, Florida.

    U.S. Market Performance

    • 7 Days: -2.7%
    • 3 Months: 10.7%
    • 1 Year: 17.5%
    • Year to Date: 5.9%
    The market has dropped by 18% in the last 7 days, with the Financials sector leading declines. In contrast to the last week, the market is actually up 18% over the past year. Looking forward, earnings are forecast to grow by 15% annually. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading